ArticleCureus2025

Comparison of Adverse Events Among Angiotensin Receptor Blockers in Hypertension Using the United States Food and Drug Administration Adverse Event Reporting System.

Toru Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.